Remote ECG Patch Screening for Asymptomatic Atrial Fibrillation: Insights from the AMALFI Trial
Highlight
This randomized clinical trial investigated remote screening for asymptomatic atrial fibrillation (AF) using a patch-based continuous ambulatory ECG monitor mailed to older adults at moderate to high stroke risk. Key findings include a modest increase in AF diagnosis over 2.5 years and higher oral anticoagulation exposure in the intervention group, although no significant difference in stroke occurrence was observed.
Study Background
MedXY registered readers
Sign in free to continue reading
Create or use your MedXY account to unlock the complete article.
This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.